Director of the Seve Ballesteros Foundation Brain Tumor group; Junior Group Leader of the BVA Foundation – CNIO Cancer Cell Biology Programme
Centro Nacional de Investigaciones Oncologicas
Massimo Squatrito, born in Italy, obtained his PhD in Applied Genetics from the University of Milan, working at the European Institute of Oncology (IEO) in the laboratory of Giulio Draetta.
After a short postdoctoral training in the laboratory of Bruno Amati at IEO, at the end of 2006 he joined the laboratory of Eric Holland, first as postdoctoral fellow and then as a Research Associate, at the Memorial Sloan-Kettering Cancer Center, New York (USA). Since then he has been focusing his research on the role of the role of the DNA damage response in the process of brain tumorigenesis and response to therapy.
At the end of October 2012 Massimo joined the BBVA Foundation – CNIO Cancer Cell Biology Programme as Junior Group Leader and director of the Seve Ballesteros Foundation Brain Tumor group.
Spanish National Cancer Research Center (CNIO)
Genetic Vulnerabilities in Supratentorial and Infratentorial Pediatric High-grade Gliomas
Gliomas are the most common central nervous system (CNS) tumors in children and adolescents, and they display a particularly broad range of clinical behavior. The impact of CNS tumors on infant mortality is very important. During the last decades there have been no advances in the prognosis of these
Identification of Novel Therapeutic Approaches for pHGGs
Novel approaches are needed in the treatment of pediatric high grade gliomas. Using cell lines provided by the Children’s Brain Tumor Network, researchers will identify novel therapeutic targets.